Chen Jin-Long
Chief Scientific Officer at NGM BIOPHARMACEUTICALS INC
- Sold, on record
- $12.2M
- Dollars the filings state
- Form 4 sales
- 20
- Latest Jan 17, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- NGM BIOPHARMACEUTICALS INCChief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale NGM BIOPHARMACEUTICALS INCPlan not statedApr 12, 2021 2021
Sold 25,000 shares at $24.65 ($616k)
Chen Jin-Long, Chief Scientific Officer
Sold 2.6% of holdings ($23.9M position)945,005 shares left1x usual sizeFiling
- 2 Form 4 sale NGM BIOPHARMACEUTICALS INCPlan not statedMay 3, 2021 +21 days
Sold 25,000 shares at $27.62 ($691k)
Chen Jin-Long, Chief Scientific Officer
Sold 2.6% of holdings ($26.1M position)920,005 shares left1x usual sizeFiling
- 3 Form 4 sale NGM BIOPHARMACEUTICALS INCPlan not statedAug 10, 2021 +99 days
Sold 30,000 shares at $23.81 ($714k)
Chen Jin-Long, Chief Scientific Officer
Sold 3% of holdings ($23.6M position)959,449 shares left1.2x usual sizeFiling
- 4 Form 4 sale NGM BIOPHARMACEUTICALS INCPlan not statedSep 14, 2021 +35 days
Sold 30,000 shares at $25.84 ($775k)
Chen Jin-Long, Chief Scientific Officer
Sold 3.1% of holdings ($24.8M position)929,449 shares left1.2x usual sizeFiling
- 5 Form 4 sale NGM BIOPHARMACEUTICALS INCPlan not statedOct 12, 2021 +28 days
Sold 30,000 shares at $20.28 ($608k)
Chen Jin-Long, Chief Scientific Officer
Sold 3.2% of holdings ($18.8M position)899,449 shares left1.2x usual sizeFiling
- 6 Form 4 sale NGM BIOPHARMACEUTICALS INCPlan not statedNov 15, 2021 +34 days
Sold 30,000 shares at $19.73 ($592k)
Chen Jin-Long, Chief Scientific Officer
Sold 3.3% of holdings ($17.7M position)869,449 shares left1.2x usual sizeFiling
- 7 Form 4 sale NGM BIOPHARMACEUTICALS INCPlan not statedDec 7, 2021 +22 days
Sold 30,000 shares at $18.41 ($552k)
Chen Jin-Long, Chief Scientific Officer
Sold 3.2% of holdings ($17.3M position)908,893 shares left1.2x usual sizeFiling
- 8 Form 4 sale NGM BIOPHARMACEUTICALS INCPlan not statedJan 17, 2023 +406 days
Sold 85,082 shares at $5.15 ($438k)
Chen Jin-Long, Chief Scientific Officer
Sold 8.6% of holdings ($5.1M position)908,893 shares left2.8x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (20)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 17, 2023 | Jan 18, 2023 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 85,082 | $438k | 8.6% | Plan not stated | SEC |
| Dec 7, 2021 | Dec 7, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 30,000 | $552k | 3.2% | Plan not stated | SEC |
| Nov 15, 2021 | Nov 16, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 30,000 | $592k | 3.3% | Plan not stated | SEC |
| Oct 12, 2021 | Oct 13, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 30,000 | $608k | 3.2% | Plan not stated | SEC |
| Sep 14, 2021 | Sep 14, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 30,000 | $775k | 3.1% | Plan not stated | SEC |
| Aug 10, 2021 | Aug 11, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 30,000 | $714k | 3.0% | Plan not stated | SEC |
| May 3, 2021 | May 4, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $691k | 2.6% | Plan not stated | SEC |
| Apr 12, 2021 | Apr 13, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $616k | 2.6% | Plan not stated | SEC |
| Mar 1, 2021 | Mar 2, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $667k | 2.5% | Plan not stated | SEC |
| Feb 16, 2021 | Feb 17, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $719k | 2.5% | Plan not stated | SEC |
| Jan 4, 2021 | Jan 6, 2021 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $732k | 2.8% | Plan not stated | SEC |
| Dec 14, 2020 | Dec 16, 2020 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $700k | 2.7% | Plan not stated | SEC |
| Nov 2, 2020 | Nov 4, 2020 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $443k | 2.6% | Plan not stated | SEC |
| Oct 12, 2020 | Oct 13, 2020 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $426k | 2.6% | Plan not stated | SEC |
| Sep 1, 2020 | Sep 3, 2020 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $446k | 2.5% | Plan not stated | SEC |
| Aug 10, 2020 | Aug 11, 2020 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $476k | 2.5% | Plan not stated | SEC |
| Jul 1, 2020 | Jul 2, 2020 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $473k | 2.4% | Plan not stated | SEC |
| Jun 15, 2020 | Jun 17, 2020 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 25,000 | $541k | 2.3% | Plan not stated | SEC |
| Jan 9, 2020 | Jan 9, 2020 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 50,765 | $916k | 4.5% | Plan not stated | SEC |
| Nov 4, 2019 | Nov 4, 2019 | NGM BIOPHARMACEUTICALS INC | Chief Scientific Officer | Form 4 sale | 50,765 | $655k | 4.8% | Plan not stated | SEC |